FDA set SUDs (single-use devices) enforcement date:
This article was originally published in Clinica
Executive Summary
The US FDA has warned that it intends to begin enforcing its premarket requirements for reprocessed single-use devices (SUDs) starting on February 14. The agency posted its "reminder to all concerned parties" on its special reuse website. Reprocessors must have approved PMAs or cleared 510(k)s for high-risk (class III) and medium-risk (class II) reprocessed devices by February 14 or risk facing an FDA enforcement action, the agency said. February 14 is also the deadline for submission of a 510(k) for class I, non-exempt, single-use devices, it noted. The FDA intends to process these latter submissions by August 14.
You may also be interested in...
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.